SCHEMBL13751422

SCHEMBL13751422

CNC(C(=O)N[C@H](C(=O)N(C)[C@H](/C=C(\C)C(C)=O)C(C)C)C(C)(C)C)C(C)(C)c1ccccc1

nearest known ligand 0.72

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
▸ TUBB1 Q9H4B7 2/20 0.72
▸ STAT6 P42226 2/20 0.35
▸ ADAM17 P78536 6/20 0.33
▸ MMP1 P03956 4/20 0.33
▸ MMP2 P08253 8/20 0.32
▸ MMP3 P08254 7/20 0.32
▸ TNF P01375 1/20 0.32
▸ MMP9 P14780 1/20 0.32
▸ MMP8 P22894 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4370422 1.00 TUBB1 (0.72) TUBB1STAT6ADAM17MMP1MMP2
SCHEMBL12202205 1.00 TUBB1 (0.72) TUBB1STAT6ADAM17MMP1MMP2
Taltobulin SCHEMBL57122 0.94 TUBB1 (0.81) TUBB1STAT6ADAM17MMP1MMP2
Taltobulin SCHEMBL13751415 0.94 TUBB1 (0.81) TUBB1STAT6ADAM17MMP1MMP2
Taltobulin SCHEMBL6799555 0.94 TUBB1 (0.81) TUBB1STAT6ADAM17MMP1MMP2
Taltobulin SCHEMBL13660106 0.94 TUBB1 (0.81) TUBB1STAT6ADAM17MMP1MMP2
Taltobulin SCHEMBL4378011 0.94 TUBB1 (0.81) TUBB1STAT6ADAM17MMP1MMP2
Taltobulin SCHEMBL58672 0.94 TUBB1 (0.81) TUBB1STAT6ADAM17MMP1MMP2
Taltobulin SCHEMBL13848320 0.94 TUBB1 (0.81) TUBB1STAT6ADAM17MMP1MMP2
Taltobulin SCHEMBL58356 0.94 TUBB1 (0.81) TUBB1STAT6ADAM17MMP1MMP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7579323-B1 Analogs of hemiasterlin wherein the indole moiety of hemiasterlin has been deleted or replaced demonstrate potent anti-mitotic and cytotoxic activity; may be useful in treatment of colon, breast, lung cancers THE UNIVERSITY OF BRITISH COLUMBIA (CA) 2009-08-25 — — US disclosed
Send feedback